Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Compass’ range

How Compass’ technology generates large multispecific libraries

Mark Zipkin, Staff Writer
August 3, 2018 11:41 PM UTC

Compass Therapeutics LLC combines human cell display, high throughput antibody screening and a multispecific engineering platform to develop large libraries of cancer and autoimmune therapies.

Traditional approaches to antibody discovery use hybridoma fusions in animals, phage display or yeast cell surface display, followed by a humanizing step, which co-founder and CEO Thomas Schuetz said generates smaller libraries of antibodies with less epitopic diversity than Compass’ approach...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Compass Therapeutics Inc.